NCT02084732View on ClinicalTrials.gov

Safety and Efficacy of Sorafenib in Patients With Advanced Thyroid Cancer: a Phase II Clinical Study

PHASE2CompletedINTERVENTIONAL
Enrollment

35

Participants

Timeline

Start Date

October 1, 2013

Primary Completion Date

November 1, 2019

Study Completion Date

November 1, 2019

Conditions
Thyroid Cancer
Interventions
DRUG

Sorafenib

drug

Trial Locations (1)

00000

Instituto Nacional de Cancerología, Bogotá

All Listed Sponsors
lead

Instituto Nacional de Cancerologia, Columbia

OTHER_GOV

NCT02084732 - Safety and Efficacy of Sorafenib in Patients With Advanced Thyroid Cancer: a Phase II Clinical Study | Biotech Hunter | Biotech Hunter